US FDA Approves First in New Class of HIV Drug

Pfizer’s maraviroc, the first in a new class of HIV drugs formulated to stop HIV virus from entering the immune system, has been approved by the US Food and Drug Administration (FDA).

The FDA has approved the drug since 50 to 60 per cent of people infected by HIV, have forms of the virus that bind to CCR5.

The drug will also have a warning of possible liver damage. In spite of these safety concerns, the drug has been put on fast-track by FDA due to increasing drug resistance. read more